NORD Issues Statement on Approval of 21st Century Cures Initiative and Introduction of OPEN Act

NORD President and CEO Peter L. Saltonstall praised the House Energy and Commerce Committee for its recent unanimous approval of the 21st Century Cures Initiative, which includes broad-ranging provisions to enhance the development and delivery of medical treatments. Mr. Saltonstall also noted the introduction in the Senate of the OPEN Act, which encourages the repurposing of approved drugs for the treatment of life-threatening rare diseases. Read the NORD statement.  

NORD President and CEO Peter L. Saltonstall praised the House Energy and Commerce Committee for its recent unanimous approval of the 21st Century Cures Initiative, which includes broad-ranging provisions to enhance the development and delivery of medical treatments. Mr. Saltonstall also noted the introduction in the Senate of the OPEN Act, which encourages the repurposing of approved drugs for the treatment of life-threatening rare diseases. Read the NORD statement.  

NORD President and CEO Peter L. Saltonstall praised the House Energy and Commerce Committee for its recent unanimous approval of the 21st Century Cures Initiative, which includes broad-ranging provisions to enhance the development and delivery of medical treatments. Mr. Saltonstall also noted the introduction in the Senate of the OPEN Act, which encourages the repurposing of approved drugs for the treatment of life-threatening rare diseases. Read the NORD statement.